Ontario Teachers Pension Plan Board Seagen Inc. Transaction History

Ontario Teachers Pension Plan Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $39,451 - $44,528	206 Added 9.02%	2,490 $528,000
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $428,569 - $471,075	2,284 New	2,284 $439,000
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $237,572 - $378,134	1,862 New	1,862 $376,000
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $429,752 - $572,209	3,177 Added 179.59%	4,946 $677,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $219,796 - $362,246	-2,020 Reduced 53.31%	1,769 $313,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $261,228 - $344,744	-2,184 Reduced 36.56%	3,789 $546,000
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $522,233 - $699,120	3,663 Added 158.57%	5,973 $923,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $329,059 - $392,284	2,310 New	2,310 $392,000
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $229,771 - $274,031	-1,701 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $71,505 - $99,216	520 Added 44.03%	1,701 $236,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $194,428 - $250,289	1,181 New	1,181 $207,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.